top of page
Sage is attending BioEurope Spring in Lisbon from March 23-25, 2026! Please click here to meet!
Menu
Close
Sage
Why Sage?
What Sage Is
What Makes Sage Different?
Our Platform
About Sage
How We Work
Services
M & A
Licensing
Track Record
Locations
Added Value
Sage Clients
Testimonials
SAGEIQ
Sage Global
Sage APAC
Sage China
Sage Japan
Sage India
Team
News
Media
Downloads
Sage 2025 Review
Meet Us!
Contact
Latest News
GLOBAL BIOSCIENCES DEALMAKERS: 30+ YEARS. 300+ CLIENTS & DEALS. BILLIONS IN VALUE.
Sage
Why Sage?
What Sage Is
What Makes Sage Different?
Our Platform
About Sage
How We Work
Services
M & A
Licensing
Track Record
Locations
Added Value
Sage Clients
Testimonials
SAGEIQ
Sage Global
Sage APAC
Sage China
Sage Japan
Sage India
Team
News
Media
Downloads
Sage 2025 Review
Meet Us!
Contact
More
Use tab to navigate through the menu items.
Sage Group News
Sage New Client: Notogen's Groundbreaking Regenerative Therapy for Degenerative Disc Disease
Sage Group's new client, Notogen, is a US registered company focused on a regenerative therapeutic, designated NTG-101, for treating...
PolyPid Announces Successful Completion of Enrollment in Phase 3 SHIELD II Trial of D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections
PETACH TIKVA, Israel, March 11, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD ) (“PolyPid” or the “Company”), a late-stage...
bottom of page
